Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eugene H. Rotberg currently holds 2,533 shares of MARTEK BIOSCIENCES CORP (MATK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eugene H. Rotberg has been a net neutral trader of MATK stock. They have purchased $0 and sold $0 worth of shares.
Eugene H. Rotberg's most recent insider trade was on Feb 25, 2011, when they sold 2,533 shares at $31.50 per share.
Eugene H. Rotberg serves as Executive at MARTEK BIOSCIENCES CORP (MATK). They have executed 9 insider transactions totaling $0 over their tenure at the company.
Eugene H. Rotberg holds the position of Executive at MARTEK BIOSCIENCES CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Eugene H. Rotberg has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Eugene H. Rotberg was on Feb 18, 2011, when they sold $1.7M worth of MATK shares. This transaction involved 55,206 shares at $31.50 per share.
Eugene H. Rotberg currently owns 2,533 shares of MARTEK BIOSCIENCES CORP (MATK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eugene H. Rotberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eugene H. Rotberg has 9 Form 4 filings on record as an insider at MARTEK BIOSCIENCES CORP.
Set alerts for Eugene H. Rotberg and 40,000+ other insiders.